⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Official Title: A Non-interventional Survey on the Epidermal Growth Factor Receptor (EGFR) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Study ID: NCT01106781

Interventions

Study Description

Brief Summary: This is a descriptive observational study. The primary objective is to explore the EGFR gene mutation status in early stage NSCLC with adenocarcinoma histology after complete resection. The patients should be histological confirmed adenocarcinoma of the lung, have received complete resection and tested for EGFR mutation in regular medical practice.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Beijing, Beijing, China

Research Site, Chongqing, Chongqing, China

Research Site, Guangzhou, Guangdong, China

Research Site, Wuhan, Hubei, China

Research Site, Nanjing, Jiangsu, China

Research Site, Suzhou, Jiangsu, China

Research Site, Changchun, Jilin, China

Research Site, Shenyang, Liaoning, China

Research Site, Qingdao, Shandong, China

Research Site, Shanghai, Shanghai, China

Research Site, Chengdu, Sichuan, China

Research Site, Tianjin, Tianjin, China

Research Site, Hangzhou, Zhejiang, China

Contact Details

Name: Karen Atkin

Affiliation: Astrazeneca China R&D

Role: STUDY_DIRECTOR

Name: Wu Yilong

Affiliation: Guangdong Provincial People's Hospital

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: